Ventana announces collaboration to develop companion diagnostics for ImmunoGen's targeted anticancer agents
Ventana Medical Systems, Inc. announced it has entered into an agreement with ImmunoGen, Inc. to collaborate on the development of biomarker assays and a companion diagnostic immunohistochemistry (IHC) test for one or more of ImmunoGen's product candidates. Under this agreement, the companies have created an initial test for folate receptor alpha (FRa, also known as folate receptor 1, or FOL1) that is being used in early trials of IMGN853, ImmunoGen's FRa-targeting antibody-drug conjugate (ADC). Cancers that highly express FRa include epithelial ovarian cancer, endometrial cancer, and types of non-small cell lung cancers (NSCLC).
The goal of the collaboration is to leverage Ventana's expertise in companion diagnostic development, from prototyping through regulatory approval and commercialization, to identify specific patient populations for ImmunoGen's bio-target directed therapies.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
High-Tech Gründerfonds, Bayern Kapital and BioM AG to invest in Intana Bioscience GmbH

Heart hormone helps shape fat metabolism - Sanford-Burnham study shows that the pathway to losing fat is heavily influenced by a hormone produced in the heart
Low-carb diets linked to atherosclerosis and impaired blood vessel growth - Study suggests that popular diet regimen may have adverse effect on body's restorative capacity

Autoimmunity: immune cells escape therapy due to "exhausted" state - Researchers have succeeded in isolating and analyzing disease-causing T cells from the blood in autoimmune diseases
Fluidity Predicts Aggressiveness of Cancerous Tumours
Biogemma and Wageningen UR announce a collaboration in wheat drought tolerance research
Harvard Apparatus Acquires PanLab s.l. - A New Acquisition by Harvard Apparatus Expands its Behavioral Sciences Product Offerings

SCIO Automation Munich GmbH - Frankenthal, Germany

SRI Instruments Europe GmbH - Bad Honnef, Germany

PBK Buschmann - Mülheim (Ruhr), Germany
